Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
- 30 November 2017
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 377 (22), 2167-2179
- https://doi.org/10.1056/nejmra1609337
Abstract
When T cells from a bone marrow donor begin to attack the host within 3 months after hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease mainly affects the skin, liver, and gastrointestinal tract and is treated with immunosuppressive drugs.Keywords
This publication has 114 references indexed in Scilit:
- Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host DiseaseThe New England Journal of Medicine, 2012
- Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationThe Journal of Experimental Medicine, 2012
- Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantationProceedings of the National Academy of Sciences of the United States of America, 2011
- The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cellsThe Journal of Experimental Medicine, 2011
- Manipulating the Bioenergetics of Alloreactive T Cells Causes Their Selective Apoptosis and Arrests Graft-Versus-Host DiseaseScience Translational Medicine, 2011
- Inhibition of Neovascularization to Simultaneously Ameliorate Graft-vs-Host Disease and Decrease Tumor GrowthJNCI Journal of the National Cancer Institute, 2010
- Circulating mitochondrial DAMPs cause inflammatory responses to injuryNature, 2010
- Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X ReceptorsPublished by Elsevier BV ,2009
- Absence of donor T-cell–derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activityBlood, 2007
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionThe Journal of Experimental Medicine, 2007